Health Care & Life Sciences » Pharmaceuticals | Shanghai Wingsung Investment Management Co. Ltd.

Shanghai Wingsung Investment Management Co. Ltd. B | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
148,797.80
206,318.20
248,588.00
235,602.40
252,461.30
275,185
Cost of Goods Sold (COGS) incl. D&A
39,774.60
46,577.10
67,687.70
83,274.30
104,360.30
112,233
Gross Income
109,023.30
159,741.10
180,900.30
152,328.20
148,101.00
162,952
SG&A Expense
86,164.50
125,282.10
139,833.70
122,859.40
126,913.60
144,234.40
EBIT
22,137.80
34,212.70
40,597.60
32,011.50
20,788.20
18,239.90
Unusual Expense
-
-
-
4.80
-
-
Non Operating Income/Expense
61.00
42.70
212.60
283.60
2,350.80
1,696.80
Interest Expense
2,135.80
403.30
777.50
742.40
2,063.00
1,562.90
Pretax Income
22,318.60
34,584.70
41,174.50
32,024.10
21,652.10
18,951.20
Income Tax
3,916.80
5,399.00
6,447.20
5,434.10
3,906.40
4,008.80
Equity in Affiliates
-
173.10
-
-
43.40
65.30
Consolidated Net Income
18,401.80
29,358.90
34,727.40
26,590.00
17,702.20
14,877.10
Net Income
18,143.40
29,240.30
34,483.10
27,404.00
19,176.80
16,033.10
Net Income After Extraordinaries
18,143.40
29,240.30
34,483.10
27,404.00
19,176.80
16,033.10
Net Income Available to Common
18,143.40
29,240.30
34,483.10
27,404.00
19,176.80
16,033.10
EPS (Basic)
0.04
0.05
0.07
0.05
0.04
0.03
Basic Shares Outstanding
461,545.00
534,071.70
534,071.60
534,071.60
534,071.60
534,071.60
EPS (Diluted)
0.04
0.05
0.06
0.05
0.04
0.03
Diluted Shares Outstanding
461,545.00
534,071.70
534,071.60
534,071.60
534,071.60
534,071.60
EBITDA
26,708.80
39,383.30
46,860.20
38,928.10
27,702.90
25,634.60
Other Operating Expense
720.90
246.20
469.10
2,542.70
399.10
477.70
Non-Operating Interest Income
99.20
229.60
349.20
476.20
576.10
547.50
Minority Interest Expense
258.40
118.60
244.30
814.00
1,474.60
1,156.10

About Shanghai Wingsung Investment Management Co.

View Profile
Address
Room 613, Changfa Building
Shanghai Shanghai 200003
China
Employees -
Website http://www.gzsq.com
Updated 07/08/2019
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. engages in the research and development, manufacture, and sale of antitumor, cardiovascular, cold and cough, children medicine, and anti fungi drugs. Its products include yening syrup, lipid detoxification, cardiovascular, high blood, and other medicines. The company was founded in 1947 and is headquartered in Shanghai, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.